These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27779786)

  • 21. Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.
    Lin SD; Tsai ST; Tu ST; Su CC; Chen JF; Lu CH; Wang CH; Yu NC; Hsu SR; Hsieh MC
    Prim Care Diabetes; 2015 Apr; 9(2):135-41. PubMed ID: 25266893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.
    Drakos SG; Wever-Pinzon O; Selzman CH; Gilbert EM; Alharethi R; Reid BB; Saidi A; Diakos NA; Stoker S; Davis ES; Movsesian M; Li DY; Stehlik J; Kfoury AG;
    J Am Coll Cardiol; 2013 May; 61(19):1985-94. PubMed ID: 23500219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative Transesophageal Echocardiography and Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Silverton NA; Patel R; Zimmerman J; Ma J; Stoddard G; Selzman CH; Morrissey CK
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2096-2103. PubMed ID: 29555387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
    Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
    Yoon NM; Cavaghan MK; Brunelle RL; Roach P
    Clin Ther; 2009 Jul; 31(7):1511-23. PubMed ID: 19695400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
    Huri HZ; Lim LP; Lim SK
    Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socio-economic position, multimorbidity, and health care utilization among Danish left ventricular assist device patients.
    Schjødt I; Mols RE; Bakos I; Horváth-Puhó E; Gustafsson F; Kristensen SL; Larsson JE; Christensen B; Eiskjær H; Løgstrup BB
    ESC Heart Fail; 2024 Aug; 11(4):1919-1931. PubMed ID: 38488159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients.
    Tan NY; Sangaralingham LR; Schilz SR; Dunlay SM
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset right ventricular dysfunction after mechanical support by a continuous-flow left ventricular assist device.
    Kapelios CJ; Charitos C; Kaldara E; Malliaras K; Nana E; Pantsios C; Repasos E; Tsamatsoulis M; Toumanidis S; Nanas JN
    J Heart Lung Transplant; 2015 Dec; 34(12):1604-10. PubMed ID: 26163154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Perioperative Right Ventricular Support Prevent Postoperative Right Heart Failure in Patients With Biventricular Dysfunction Undergoing Left Ventricular Assist Device Implantation?
    Deschka H; Holthaus AJ; Sindermann JR; Welp H; Schlarb D; Monsefi N; Martens S; Scherer M
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):619-26. PubMed ID: 27321789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.
    Birks EJ; Drakos SG; Patel SR; Lowes BD; Selzman CH; Starling RC; Trivedi J; Slaughter MS; Alturi P; Goldstein D; Maybaum S; Um JY; Margulies KB; Stehlik J; Cunningham C; Farrar DJ; Rame JE
    Circulation; 2020 Nov; 142(21):2016-2028. PubMed ID: 33100036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?†.
    Patil NP; Mohite PN; Sabashnikov A; Dhar D; Weymann A; Zeriouh M; Koch A; Garcia-Saez D; Zych B; Hards R; Hedger M; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Popov AF; Banner N; Simon AR
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):788-94. PubMed ID: 26108216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated left ventricular assist device implantation produces variable changes to patient body mass index.
    Chandratre SR; Smith NJ; Walsh RW; Kindel TL; Sundararajan SK; Joyce DL; Mohammed A
    Artif Organs; 2022 Aug; 46(8):1597-1607. PubMed ID: 35261065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.